Quellis Biosciences

BiotechnologySeries ABoston, USquellisbio.com

Latest round

Series A

Last raised

Dec 2019

Total raised

$17M

Investors

2

About Quellis Biosciences

Based in Massachusetts, US and founded in 2017, Quellis Biosciences provides medicines for patients with life-threatening rare diseases and underserved by current treatment options. The company develops new monoclonal antibodies that help the immune system’s ability to fight off harmful antigens such as viruses. in 2021. The company works with pharmaceutical companies, by developing medicine with monoclonal antibodies for patients with rare diseases. Quellis Biosciences will offer their different developed therapies intended for a specific disease, pharmaceutical companies will then choose to manufacture and commercialized for public access.

Who invested in Quellis Biosciences

2 investors across 1 round

See all investors in Quellis Biosciences

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Dec 10, 2019

    Amount

    $17M

    Investors

    Locked

Questions about Quellis Biosciences

Who invested in Quellis Biosciences?

Quellis Biosciences has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Quellis Biosciences raised?

Quellis Biosciences has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Quellis Biosciences last raise money?

Quellis Biosciences's most recent round on record is a Series A, in Dec 2019.

What does Quellis Biosciences do?

Based in Massachusetts, US and founded in 2017, Quellis Biosciences provides medicines for patients with life-threatening rare diseases and underserved by current treatment options.

Where is Quellis Biosciences headquartered?

Quellis Biosciences is headquartered in Boston, US.

Which VCs invest in companies like Quellis Biosciences?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Quellis Biosciences's stage. Their profiles are linked below.

Raising like Quellis Biosciences? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.